Allspring Global Investments’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$235K Buy
788
+144
+22% +$42.4K ﹤0.01% 1627
2026
Q1
$201K Buy
+644
New +$208K ﹤0.01% 1608
2024
Q4
Sell
-162
Closed -$36.4K 2470
2024
Q3
$36.4K Buy
+162
New +$29.1K ﹤0.01% 1894
2023
Q2
Sell
-40
Closed -$8.62K 2863
2023
Q1
$8.62K Hold
40
﹤0.01% 2612
2022
Q4
$8.8K Hold
40
﹤0.01% 2733
2022
Q3
$5K Hold
40
﹤0.01% 2785
2022
Q2
$6K Buy
+40
New +$6.25K ﹤0.01% 2612

Other funds holding ONC

Allspring Global Investments's ONC Position: Q2 2026 in Review

Allspring Global Investments increased its BeOne Medicines Ltd (ONC) stake by 22% in Q2 2026, buying an estimated $42.4K and bringing the position to 788 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Allspring Global Investments first reported a position in ONC in Q2 2022 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Allspring Global Investments held 788 shares of BeOne Medicines Ltd worth $235K as of Q2 2026.
  • Allspring Global Investments bought 144 BeOne Medicines Ltd shares in Q2 2026, an estimated $42.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1627 holding.
  • Allspring Global Investments first reported a position in BeOne Medicines Ltd in Q2 2022 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.